XML 18 R4.htm IDEA: XBRL DOCUMENT v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE INCOME - USD ($)
shares in Thousands, $ in Thousands
3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Revenue:    
Total Revenue $ 127,427 $ 39,082
Cost of sales (exclusive of amortization of intangibles) 12,005 1,545
Amortization of intangibles 10,300 52
Gross profit 105,122 37,485
Operating Expenses:    
Research and development 7,212 3,193
Selling and marketing 12,532 4,474
General and administrative 21,720 9,693
Total Operating Expenses 41,464 17,360
Income From Operations 63,658 20,125
Other (Expense) Income:    
Unrealized loss on marketable security (3,546) 0
Change in contingent consideration (4,199) 0
Other non-operating (expense) income, net (268) 519
Total Other (Expense) Income (8,013) 519
Income before income taxes 55,645 20,644
Tax expense 17,044 0
Net Income 38,601 20,644
Other Comprehensive Loss:    
Unrealized loss from investments (1) (5)
Foreign currency translation loss 0 (1)
Total Other Comprehensive Loss (1) (6)
Comprehensive Income $ 38,600 $ 20,638
Net Income Per Common Share – Basic (in dollars per share) $ 0.48 $ 0.32
Net Income Per Common Share - Diluted (in dollars per share) $ 0.43 $ 0.30
Weighted Average Common Shares Outstanding – Basic (in shares) 79,509 65,244
Weighted Average Common Shares Outstanding – Diluted (in Shares) 92,985 68,975
Product sales, net    
Revenue:    
Total Revenue $ 121,916 $ 39,082
Contract revenue    
Revenue:    
Total Revenue $ 5,511 $ 0